We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWV icon
1226
iShares Russell 3000 ETF
IWV
$19.5B
$300K 0.01%
1,177
+3
+0.3% +$785
SEDG icon
1227
SolarEdge
SEDG
$2.54B
$299K 0.01%
1,129
-854
-43% -$232K
PDI icon
1228
PIMCO Dynamic Income Fund
PDI
$7.44B
$297K 0.01%
11,179
+242
+2% +$6.79K
CDNS icon
1229
Cadence Design Systems
CDNS
$91.7B
$296K 0.01%
+1,952
New +$297K
UTL icon
1230
Unitil
UTL
$980M
$296K 0.01%
6,925
JOET icon
1231
Virtus Terranova US Quality Momentum ETF
JOET
$241M
$295K 0.01%
+9,964
New +$303K
QQQJ icon
1232
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.12B
$295K 0.01%
8,929
+420
+5% +$14.3K
BBN icon
1233
BlackRock Taxable Municipal Bond Trust
BBN
$971M
$294K 0.01%
11,398
TVRD
1234
Tvardi Therapeutics
TVRD
$19.7M
$294K 0.01%
+529
New +$265K
EPAC icon
1235
Enerpac Tool Group
EPAC
$1.86B
$293K 0.01%
14,150
-77
-0.5% -$1.92K
NZF icon
1236
Nuveen Municipal Credit Income Fund
NZF
$2.41B
$293K 0.01%
17,532
+6
+0% +$104
SCHF icon
1237
Schwab International Equity ETF
SCHF
$67B
$293K 0.01%
15,152
-664
-4% -$13.2K
CNR
1238
DELISTED
Cornerstone Building Brands, Inc.
CNR
$292K 0.01%
20,000
BME icon
1239
BlackRock Health Sciences Trust
BME
$563M
$291K 0.01%
6,106
+1,426
+30% +$69.5K
NUV icon
1240
Nuveen Municipal Value Fund
NUV
$1.92B
$291K 0.01%
25,715
+2,989
+13% +$34.7K
OPY icon
1241
Oppenheimer Holdings
OPY
$1.19B
$291K 0.01%
6,428
+1,000
+18% +$45K
CANO
1242
DELISTED
Cano Health, Inc.
CANO
$291K 0.01%
+230
New +$279K
PCN
1243
PIMCO Corporate & Income Strategy Fund
PCN
$873M
$290K 0.01%
16,079
+87
+0.5% +$1.62K
IWR icon
1244
iShares Russell Mid-Cap ETF
IWR
$56.1B
$289K 0.01%
3,690
-55
-1% -$4.41K
NMZ icon
1245
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$289K 0.01%
19,609
+1,115
+6% +$17.2K
GAB icon
1246
Gabelli Equity Trust
GAB
$1.76B
$288K 0.01%
43,234
-2,171
-5% -$14.7K
NAD icon
1247
Nuveen Quality Municipal Income Fund
NAD
$2.73B
$286K 0.01%
18,329
-937
-5% -$15.2K
YORW icon
1248
York Water
YORW
$501M
$286K 0.01%
6,542
-26
-0.4% -$1.25K
AES icon
1249
AES
AES
$10.6B
$285K 0.01%
12,507
+795
+7% +$19.3K
CHTR icon
1250
Charter Communications
CHTR
$16.9B
$284K 0.01%
390
-8
-2% -$6.07K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.